山東新華製藥股份(00719.HK)擬1944萬元收購萬博化工33%股權持股升至73%
格隆匯10月11日丨山東新華製藥股份(00719.HK)公佈,公司獲通知就山東新華萬博化工有限公司33%股權進行的競標經已完成,本公司以掛牌價人民幣1944萬元中標。隨着本公司中標,本公司已就萬博權益訂立股權轉讓協議,本公司將就萬博權益支付人民幣1944萬元作為代價予華魯控股集團。
萬博化工為一家於中國註冊成立的有限責任公司,主營業務包括生產及銷售硫酸二甲酯、異丁基苯、硫酸、二氮雜二環、四甲基胍等化學產品以及銷售化工原料。萬博化工於2016年度、2017年度及2018年度分別取得營業利潤381.3萬元、675.91萬元及614.52萬元。
於本公司2018年收購了萬博化工40%的股本後,萬博化工目前由華魯控股集團擁有其60%的股本及本公司擁有其40%的股本。協議項下的交易完成後,本公司將擁有萬博化工73%的股本。
公司稱,股權轉讓預期推進本集團的上游醫藥中間體資源、業內整體競爭力和發展以及業績表現的整合。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.